Ana I. Stancic
2011
In 2011, Ana I. Stancic earned a total compensation of $1.2M as Former Principal Executive Officer, Executive Vice President, Chief Operating Officer and Chief Financial Officer at Enzon Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $117,000 |
---|---|
Option Awards | $376,914 |
Salary | $201,462 |
Stock Awards | $542,150 |
Other | $6,044 |
Total | $1,243,569 |
Stancic received $542.2K in stock awards, accounting for 44% of the total pay in 2011.
Stancic also received $117K in non-equity incentive plan, $376.9K in option awards, $201.5K in salary and $6K in other compensation.
Rankings
In 2011, Ana I. Stancic's compensation ranked 4,872nd out of 10,747 executives tracked by ExecPay. In other words, Stancic earned more than 54.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,872 out of 10,747 | 55th |
Division Manufacturing | 1,749 out of 3,960 | 56th |
Major group Chemicals And Allied Products | 366 out of 1,033 | 65th |
Industry group Drugs | 222 out of 781 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 36 out of 157 | 77th |
Source: SEC filing on October 11, 2013.
Stancic's colleagues
We found three more compensation records of executives who worked with Ana I. Stancic at Enzon Pharmaceuticals in 2011.